Cytochrome Completed Phase 1 Trials for Losartan (DB00678)

IndicationStatusPhase
DBCOND0048068 (Cytochrome)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01187862Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of CytochromesDiagnostic